【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Targeted therapy – Market size and forecast 2018-2023
• Chemotherapy – Market size and forecast 2018-2023
• Immunotherapy – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Emergence of pipeline molecules
• Development of diagnostic tests and predictive markers
• Increasing research in regenerative medicines
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Mylan NV
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 14: EXPLORE TECHNAVIO
Exhibit 01: Vendors: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Targeted therapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Targeted therapy – Year-over-year growth 2019-2023 (%)
Exhibit 22: Chemotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Chemotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 24: Immunotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Immunotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Boehringer Ingelheim International GmbH – Vendor overview
Exhibit 51: Boehringer Ingelheim International GmbH – Product segments
Exhibit 52: Boehringer Ingelheim International GmbH – Organizational developments
Exhibit 53: Boehringer Ingelheim International GmbH – Geographic focus
Exhibit 54: Boehringer Ingelheim International GmbH – Segment focus
Exhibit 55: Boehringer Ingelheim International GmbH – Key offerings
Exhibit 56: Boehringer Ingelheim International GmbH – Key customers
Exhibit 57: Bristol-Myers Squibb Co. – Vendor overview
Exhibit 58: Bristol-Myers Squibb Co. – Product segments
Exhibit 59: Bristol-Myers Squibb Co. – Organizational developments
Exhibit 60: Bristol-Myers Squibb Co. – Geographic focus
Exhibit 61: Bristol-Myers Squibb Co. – Key offerings
Exhibit 62: Bristol-Myers Squibb Co. – Key customers
Exhibit 63: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. – Product segments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 69: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 70: Merck & Co. Inc. – Vendor overview
Exhibit 71: Merck & Co. Inc. – Product segments
Exhibit 72: Merck & Co. Inc. – Organizational developments
Exhibit 73: Merck & Co. Inc. – Geographic focus
Exhibit 74: Merck & Co. Inc. – Segment focus
Exhibit 75: Merck & Co. Inc. – Key offerings
Exhibit 76: Merck & Co. Inc. – Key customers
Exhibit 77: Mylan NV – Vendor overview
Exhibit 78: Mylan NV – Product segments
Exhibit 79: Mylan NV – Organizational developments
Exhibit 80: Mylan NV – Geographic focus
Exhibit 81: Mylan NV – Segment focus
Exhibit 82: Mylan NV – Key offerings
Exhibit 83: Mylan NV – Key customers
Exhibit 84: Novartis AG – Vendor overview
Exhibit 85: Novartis AG – Product segments
Exhibit 86: Novartis AG – Organizational developments
Exhibit 87: Novartis AG – Geographic focus
Exhibit 88: Novartis AG – Segment focus
Exhibit 89: Novartis AG – Key offerings
Exhibit 90: Novartis AG – Key customers
Exhibit 91: Otsuka Holdings Co. Ltd. – Vendor overview
Exhibit 92: Otsuka Holdings Co. Ltd. – Product segments
Exhibit 93: Otsuka Holdings Co. Ltd. – Organizational developments
Exhibit 94: Otsuka Holdings Co. Ltd. – Geographic focus
Exhibit 95: Otsuka Holdings Co. Ltd. – Segment focus
Exhibit 96: Otsuka Holdings Co. Ltd. – Key offerings
Exhibit 97: Otsuka Holdings Co. Ltd. – Key customers
Exhibit 98: Pfizer Inc. – Vendor overview
Exhibit 99: Pfizer Inc. – Product segments
Exhibit 100: Pfizer Inc. – Organizational developments
Exhibit 101: Pfizer Inc. – Geographic focus
Exhibit 102: Pfizer Inc. – Segment focus
Exhibit 103: Pfizer Inc. – Key offerings
Exhibit 104: Pfizer Inc. – Key customers
Exhibit 105: Takeda Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 106: Takeda Pharmaceutical Co. Ltd. – Product segments
Exhibit 107: Takeda Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 108: Takeda Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 109: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibit 110: Takeda Pharmaceutical Co. Ltd. – Key customers
Exhibit 111: Teva Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 112: Teva Pharmaceutical Industries Ltd. – Product segments
Exhibit 113: Teva Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 114: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibit 115 Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibit 116: Teva Pharmaceutical Industries Ltd. – Key customers
Exhibit 117: Validation techniques employed for market sizing
Exhibit 118: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：慢性骨髄性白血病治療法の世界市場2019-2023■ 英文：Chronic Myelogenous Leukemia Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日：2019年8月28日
■ 調査会社：Technavio
■ 商品コード：IRTNTR31940
■ 調査対象地域：グローバル、アジア太平洋、ヨーロッパ、北米、その他
- DRaaS（ディザスタリカバリのクラウドサービス）の世界市場：ディザスタ計画及びテスト、リアルタイム複製、バックアップソリューションDRaaS enables backup of all crucial data on a secondary storage, hosted or virtual machines. DRaaS solutions comprise DR planning and testing, real-time replication, backup solution, and data security and compliance. Disaster recovery plans provide business continuity, irrespective of any kind of interruption, such as power failures, IT system crashes, natural disasters, supply chain problems, and …
- 精密収穫の世界市場予測（～2023年）Precision harvesting market anticipated to grow at CAGR of 10.94% from 2018 to 2023The precision harvesting market was worth USD 10.4 billion in 2018 and is projected to reach USD 17.5 billion by 2023, at a CAGR of 10.94% during 2018–2023. The major factors driving the growth of the precision harvesting market are increasing farm mechanization in developing countries in Asia Pacific and Africa, in …
- 組み込みソフトウェアの世界市場2017-2021ABSTRACTAbout Embedded Software Embedded software is a computer program or code running on hardware, guiding and controlling the actions of the device. It acts as an interface between underlying hardware and end-users. It is built into hardware systems, written on computer chips, and applied in real-time systems such as ATMs, missiles, and airplanes. Examples of embedded software in our daily life …
- 世界の生体活性ガラス市場2015The Global Bioactive Glass Industry Report 2015 is a professional and in-depth study on the current state of the Bioactive Glass industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Bioactive Glass market analysis is provided for the international markets including development trends, competitive lands …
- 世界のアルコール飲料市場2015The Global Alcoholic Drinks Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Alcoholic Drinks industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Alcoholic Drinks market analysis is provided for the international markets including development trends, …
- 自動車用可変容量ターボチャージャー（VGT）の世界市場About Automotive VGT An automotive turbocharger is a component that helps the engine to produce additional power and improves the overall performance of the vehicle. The turbocharger has two components: turbine and compressor. It uses the exhaust air that is released after fuel and air combustion in a vehicle combustion chamber. When this exhaust air strikes the turbine blades, it causes the turbi …
- 永久磁石の世界市場分析：材料別（アルミニウムニッケルコバルト（AlNiCo）、フェライト、サマリウムコバルト（SaCo）、ネオジム鉄ホウ素（NdFeB））、用途別（自動車、電子、産業、エネルギー、航空宇宙、医療）、セグメント予測The permanent magnet market is expected to reach USD 30.44 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to exhibit significant growth owing to increasing use of high performance products as radar arrays, fluid flow meters, door actuators and braking systems in aircraft. In addition, growing adoption of the product in space applications coupled with …
- オートモーティブバッテリーの世界市場：自動車用/船舶用/航空機用バッテリーThe demand for lead acid batteries is governed by vehicle production. Battery replacements have reduced as new technologies have extended battery life. With the switch to electronic braking and steering by wire in upscale cars, the 3kW capability of the single 12-volt battery will no longer be sufficient, ushering in the 42-volt system. Two 12-volt batteries may be the interim solution. Hybrid veh …
- 微小中空ガラス球状体の世界市場Hollow glass microspheres have evolved as a lightweight filler to be used in several industries such as aerospace, automotive, oil & gas, healthcare, and others. They are suitable to be used in various applications such as thermoplastics, rubber & elastomers, abrasive materials, sheet molding compounds, cryogenic technology, thermosets-epoxy, acoustic and thermal insulating materials, polyurethane …
- 耳ベース補聴器の世界市場2017-2021About Ear-Based Hearing AidsThe technological advancements have led to the introduction of innovative in-the-ear products in the market. The battery operated conventional devices have been replaced by advanced, wireless hearing aid devices. The rise in the prevalent cases of hearing loss and transition in the demographics has contributed to the increased use of hearing aids. However, the market fa …
- 世界の自動車金融市場動向：Global Automotive Financing Market 2014-2018TechNavio's analysts forecast the Global Automotive Financing market to grow at a CAGR of 13.12 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increase in automobile sales. The Global Automotive Financing market has also been witnessing the increasing dominance of banks in the emerging markets. However, the uncertainty in calculation of residual …
- アメリカの呼吸装置市場United States Respiratory Devices Market Outlook to 2021 Summary GlobalData’s new report, "United States Respiratory Devices Market Outlook to 2021", provides key market data on the United States Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Vent …
- 自動灌漑装置の世界市場2017-2021About Automatic Irrigation Equipment Automatic irrigation equipment is used to irrigate the field with minimum manual intervention, make the process more efficient, and allow workers to concentrate on other important farming tasks. Automatic irrigation systems are promoted by vendors and governments worldwide to minimize water wastage during irrigation and increase crop yield. As a result, there h …
- 動物用成長促進剤および機能向上剤の世界市場：抗生物質、ホルモン、飼料用酵素、プロバイオティクス、プレバイオティクス、有機酸、植物、βアゴニストThe animal growth promoters market is expected to reach USD 9.60 Billion in 2020 from USD 7.56 Billion in 2015, growing at a CAGR of 5%. The global animal growth promoters market is segmented on the basis of product and animal. By product, the market is categorized into antibiotics, hormonal growth promoters, beta agonist growth promoters, feed enzymes, probiotics and prebiotics, organic acids, ph …
- 口腔ケア/口腔衛生の世界市場予測（～2025年）The oral care/oral hygiene market is projected to reach USD 53.3 billion by 2025 from USD 44.5 billion in 2019, at a CAGR of 3.0%. Factors such as the rising prevalence of dental diseases, growing awareness about oral health, growing geriatric population associated with edentulism, and growing number of small/private dental clinics with dental dispensaries are expected to drive the growth of the o …
